United States · Biopharma startup
United States · Dianthus Therapeutics
Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach.
Funding reportedLast round: Post-IPO Equity
What company datasets say Dianthus Therapeutics raised
Funding, as reported
Reported in all$719Min dollars
Last roundPost-IPO Equity
Investors listed5
SEC Form D$123M sold, 5 filings, last Apr 2022
Founders and team
From the SEC filings it signed: 2 on the team.
- Kenneth Evan ThompsonExecutive Officeri
- Marino GarciaExecutive Officer, Directori
On the board, as filediJonathan Evan ViolinLei Evan MengLeon O. MoulderPaula Evan SoteropoulosTomas Evan Kiselak
Biopharma in United States
Startups like it
Altos LabsSan Francisco · founded 2021
VaxcyteSan Carlos · founded 2013
Madrigal PharmaceuticalsConshohocken · founded 2011
Harmony BiosciencesPlymouth Meeting · founded 2017
Kura OncologyLa Jolla · founded 2014
ImmunovantNew York · founded 2018
SolugenHouston · founded 2016
Day One BiopharmaceuticalsSouth San Francisco · founded 2018
Is this your company?
Add your raise, your deck and your story, and put Dianthus Therapeutics in front of investors. Or tell us what we have wrong.